▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Eurostars Innovative SMEs: deadline is on 13 April 2023

Eurostars supports innovative SMEs and project partners by funding international collaborative R&D and innovation projects.

Funding

Deadline of 13 April 2023 is coming for the Innovative SMEs European project. As part of the European Innovative SMEs initiative, the Eurostars tender aims to finance small and medium-sized enterprises that wish to collaborate in research and development projects to create innovative products, processes or services for business.

The initiative is aimed at: small and medium-sized enterprises (SMEs), Innovative PMI and Startups eventually in partnership, with research organizations and/or with large companies.

The italian Government allocates a total of 14 million euros to the co-financing of the Italian companies selected in the joint transnational tenders. Of these resources, those earmarked for the 2023 tender "Eurostars 3 CoD 4" amount to 7 million , for a maximum grant of 500 thousand euros per single project. A share of 40% of the allocation will be reserved for companies located in the Italian South Area.

Businesses and interested parties who intend to join the initiative must participate in both the European tender and the national tender. The deadlines for participation in the 2023 European tender expire on 13 April 2023. The methods and deadlines for submitting applications to the national tender were defined by the Directorial Decree of 3 March 2023 and applications must be submitted by 2.00 pm on 13 April 2023.

How to partecipate to Eurostars Innovative SMEs

The application must be sent, complete with all the required documentation, electronically to the PEC address dgiai.div6@pec.mise.gov.it by 2 pm on 13 April 2023.

MIMIT (Italian Ministero delle Imprese e del Made in Italy) carries out the preliminary investigation and evaluates the project within 70 days, based on a specific grid (technical characteristics, costs, financial impact, environmental and social impact), calculating the subsidies due on the basis of the total cost deemed eligible and communicating the positive outcome to be used for subsequent fulfilments.

The European initiative Innovative SMEs - implemented in the form of a Cofunded Partnership and managed by the EUREKA Secretariat - aims to help innovative SMEs to increase their research and innovation capacity and their productivity and to enable them to integrate into global value and into new markets, following three strategic objectives:

  • Innovation
  • Internationalization
  • Connecting the European Research Area (ERA - European Research Area).
If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Resecurity to Exhibit at DSEI Japan 2025, Showcasing AI-Driven Cybersecurity…

Resecurity, a U.S.-based leader in cyber threat intelligence and risk management solutions, is proud to announce its participation in DSEI Japan 2025,…

Generational Group Advises Elarasys Worldwide, LLC and IT Hardware Plus,…

Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Elarasys Worldwide,…

BostonGene to Showcase its Multimodal AI Platform Advancing Drug Development…

BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced that six abstracts have been accepted at the 2025 ASCO…

LICT Corporation Reports 2025 First Quarter Results

LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports financial results for the quarter ended March 31, 2025. Total revenues for the first…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!